B10 L-BPA Injection
2024-08-015B
Phase 2 small_molecule completed
Quick answer
B10 L-BPA Injection for Meningioma is a Phase 2 program (small_molecule) at Heron Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Heron Therapeutics
- Indication
- Meningioma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed